Go offline with the Player FM app!
1527: Dr. James McCarter Is A Strong Voice For Keto Nutrition In Clinical Research
Archived series ("Inactive feed" status)
When? This feed was archived on March 09, 2023 13:12 (). Last successful fetch was on January 23, 2023 10:11 ()
Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 237840932 series 2279160
Keto researcher Dr. James McCarter is our special interview guest on Episode 1527 of The Livin’ La Vida Low-Carb Show.
Dr. James McCarter is an experienced executive and researcher with a track-record of success in early-stage life-science technology companies. Most recently, he led research and clinical operations for San Francisco-based Virta Health, a tech-enabled nationwide medical provider that delivers the first clinically-proven treatment to safely and sustainably reverse type 2 diabetes without medications or surgery. Dr. McCarter directed the Virta – Indiana University Health clinical trial proving reversal of diabetes with medically supervised nutritional ketosis resulting in changes to the American Diabetes Association standards of care and consensus statement on nutrition in 2019.
Listen in today as Jimmy and Dr. McCarter dig into the exciting results of the Virta Health study, how this study changed the thinking of the American Diabetes Association, the profound effects that his group saw with participants from year one to year two, how this information is helping to bring keto to the mainstream, and much more.
“This way of eating should pay health dividends in the long run by allowing people to scale back and possibly remove their dependence on diabetes medicines.”
— Dr. James McCarterVirta Peer-reviewed Publications.
T2D 2y – main diabetes outcomes paper (2 year) – In Press, Frontiers in Endocrinology T2D 1y – main diabetes outcomes paper (1 year) – Diabetes Therapy CVD 1y – cardiovascular outcomes paper (1 year) – Cardiovascular Diabetology NAFLD – liver markers (1 year) – BMJ Open Sleep – patient self-reported sleep outcomes (1 year) – Sleep Medicine T2D 70d – early results (70 day) – JMIR Diabetes Economics 2y – system utilization (2 year) – In Peer Review Virta Reviews Nutritional recommendations for type 2 diabetes Type 2 diabetes reversal and remission Cardiovascular whitepaper
472 episodes
Archived series ("Inactive feed" status)
When? This feed was archived on March 09, 2023 13:12 (). Last successful fetch was on January 23, 2023 10:11 ()
Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 237840932 series 2279160
Keto researcher Dr. James McCarter is our special interview guest on Episode 1527 of The Livin’ La Vida Low-Carb Show.
Dr. James McCarter is an experienced executive and researcher with a track-record of success in early-stage life-science technology companies. Most recently, he led research and clinical operations for San Francisco-based Virta Health, a tech-enabled nationwide medical provider that delivers the first clinically-proven treatment to safely and sustainably reverse type 2 diabetes without medications or surgery. Dr. McCarter directed the Virta – Indiana University Health clinical trial proving reversal of diabetes with medically supervised nutritional ketosis resulting in changes to the American Diabetes Association standards of care and consensus statement on nutrition in 2019.
Listen in today as Jimmy and Dr. McCarter dig into the exciting results of the Virta Health study, how this study changed the thinking of the American Diabetes Association, the profound effects that his group saw with participants from year one to year two, how this information is helping to bring keto to the mainstream, and much more.
“This way of eating should pay health dividends in the long run by allowing people to scale back and possibly remove their dependence on diabetes medicines.”
— Dr. James McCarterVirta Peer-reviewed Publications.
T2D 2y – main diabetes outcomes paper (2 year) – In Press, Frontiers in Endocrinology T2D 1y – main diabetes outcomes paper (1 year) – Diabetes Therapy CVD 1y – cardiovascular outcomes paper (1 year) – Cardiovascular Diabetology NAFLD – liver markers (1 year) – BMJ Open Sleep – patient self-reported sleep outcomes (1 year) – Sleep Medicine T2D 70d – early results (70 day) – JMIR Diabetes Economics 2y – system utilization (2 year) – In Peer Review Virta Reviews Nutritional recommendations for type 2 diabetes Type 2 diabetes reversal and remission Cardiovascular whitepaper
472 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.